首页> 外文会议>IEEE International Conference on Bioinformatics and Biomedicine >Improving Disease Named Entity Recognition for Clinical Trial Matching
【24h】

Improving Disease Named Entity Recognition for Clinical Trial Matching

机译:改善疾病命名实体识别以进行临床试验匹配

获取原文

摘要

Disease named entity recognition (NER) is an important enabling technology to develop various downstream biomedical natural language processing applications. This is a challenging task, which requires addressing potential ambiguities due to variable contextual usage of the disease name mentions in clinical texts. In particular, clinical trial texts have unique complexities compared to patient-focused clinical reports or information-rich biomedical research articles, as they typically define drug testing eligibility requirements for patient cohorts via compound contextual and logical relationships. In this paper, we propose a novel disease NER model for clinical trial texts by using deep contextual embeddings with relevant domain-specific features, word embeddings, and character embeddings in a bidirectional long short-term memory network-conditional random field (BiLSTM-CRF) framework. Experiments and analyses on a clinical trial dataset and the benchmark NCBI scientific article dataset show the effectiveness of the proposed model.
机译:名为实体识别(NER)的疾病是开发各种下游生物医学自然语言处理应用程序的重要使能技术。这是一项具有挑战性的任务,由于临床文本中提到的疾病名称的上下文使用存在差异,因此需要解决潜在的歧义。特别是,与以患者为中心的临床报告或信息丰富的生物医学研究文章相比,临床试验文本具有独特的复杂性,因为它们通常通过复合的上下文和逻辑关系定义患者队列的药物测试资格要求。在本文中,我们通过在双向长短期记忆网络条件随机场(BiLSTM-CRF)中使用具有相关领域特定特征的深层上下文嵌入,单词嵌入和字符嵌入,为临床试验文本提出了一种新颖的疾病NER模型) 框架。在临床试验数据集和基准NCBI科学文章数据集上进行的实验和分析表明了该模型的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号